Marisa Nimrod, MD, MPH

Most stories about AI governance begin in a research lab or a venture-funded office park. This one begins in Trinidad and Tobago, where Marisa Nimrod spent two decades building a medical career across an entire region.

She earned her MD and MPH at St. George's University, then moved through Caribbean medicine with unusual range: Chief Medical Officer of a community hospital, President of the Trinidad and Tobago Medical Association, Executive Producer at One Caribbean Media, and — for eight years running — CEO of the Caribbean Association of Oncology and Hematology. CAOH is the region's convening authority for cancer care. When oncology policy changes in the Caribbean, it tends to start in her office.

When CANONIC needed evidence that governed AI could function outside the heavily regulated American healthcare system, Dr. Nimrod did not request a pilot program or a feasibility study. She opened her clinical network. What followed were 108 community learning sessions across twelve Caribbean nations, endorsements from the fifteen-member Organization of Eastern Caribbean States, and alignment with CARICOM.

The Caribbean has no AI legislation. There is no federal framework, no FDA equivalent, no regulatory apparatus to lean on. What it does have is a mosaic of health systems spanning twelve nations, multiple languages, and vast disparities in clinical infrastructure — the exact conditions under which ungoverned AI is most dangerous and governed AI most necessary. Dr. Nimrod proved that governance works not because a regulator demands it but because the population health reality demands it. She is co-inventor on five CANONIC patent filings, Co-Investigator on the Community Learning Study, and the reason the July 2026 CAOH Scientific Conference in Trinidad will feature governed AI on the program.